Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Antilymphocyte Serum × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 4 Hematologic Neoplasms 4 Myeloproliferative Disorders 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hodgkin Disease 3 Bone Marrow Failure Disorders 3 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Recurrence 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Non-Malignant Neoplasm 1 Neuromyelitis Optica 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1

Interventions

Nivolumab 3 poly ICLC 2 Specimen Handling 2 Sorafenib 2 Irinotecan 2 Ipilimumab 2 sapanisertib 1 pembrolizumab 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1 atezolizumab 1 aflibercept 1 Watchful Waiting 1 Vincristine 1 Surveys and Questionnaires 1 Platinum 1 Oxaliplatin 1 Observation 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡